Polymorphisms of interferon-inducible genes OAS-1 and MxA associated with SARS in the Vietnamese population - PubMed (original) (raw)

. 2005 Apr 22;329(4):1234-9.

doi: 10.1016/j.bbrc.2005.02.101.

Minako Hijikata, Satoru Itoyama, Tran Quy, Nguyen Chi Phi, Hoang Thuy Long, Le Dang Ha, Vo Van Ban, Ikumi Matsushita, Hideki Yanai, Fumiko Kirikae, Teruo Kirikae, Tadatoshi Kuratsuji, Takehiko Sasazuki, Naoto Keicho

Affiliations

Polymorphisms of interferon-inducible genes OAS-1 and MxA associated with SARS in the Vietnamese population

Emi Hamano et al. Biochem Biophys Res Commun. 2005.

Abstract

We hypothesized that host antiviral genes induced by type I interferons might affect the natural course of severe acute respiratory syndrome (SARS). We analyzed single nucleotide polymorphisms (SNPs) of 2',5'-oligoadenylate synthetase 1 (OAS-1), myxovirus resistance-A (MxA), and double-stranded RNA-dependent protein kinase in 44 Vietnamese SARS patients with 103 controls. The G-allele of non-synonymous A/G SNP in exon 3 of OAS-1 gene showed association with SARS (p=0.0090). The G-allele in exon 3 of OAS-1 and the one in exon 6 were in strong linkage disequilibrium and both of them were associated with SARS infection. The GG genotype and G-allele of G/T SNP at position -88 in the MxA gene promoter were found more frequently in hypoxemic group than in non-hypoxemic group of SARS (p=0.0195). Our findings suggest that polymorphisms of two IFN-inducible genes OAS-1 and MxA might affect susceptibility to the disease and progression of SARS at each level.

PubMed Disclaimer

References

    1. World Health Organization (2003), Consensus document on the epidemiology of severe acute respiratory syndrome (SARS), WHO/CDS/CSR/GAR/2003.11, Geneva
    1. Booth C.M., Matukas L.M., Tomlinson G.A., Rachlis A.R., Rose D.B., Dwosh H.A., Walmsley S.L., Mazzulli T., Avendano M., Derkach P., Ephtimios I.E., Kitai I., Mederski B.D., Shadowitz S.B., Gold W.L., Hawryluck L.A., Rea E., Chenkin J.S., Cescon D.W., Poutanen S.M., Detsky A.S. Clinical features and short-term outcomes of 144 patients with SARS in the greater Toronto area. Jama. 2003;289:2801–2809. - PubMed
    1. Chan J.W., Ng C.K., Chan Y.H., Mok T.Y., Lee S., Chu S.Y., Law W.L., Lee M.P., Li P.C. Short term outcome and risk factors for adverse clinical outcomes in adults with severe acute respiratory syndrome (SARS) Thorax. 2003;58:686–689. - PMC - PubMed
    1. Lin M., Tseng H.K., Trejaut J.A., Lee H.L., Loo J.H., Chu C.C., Chen P.J., Su Y.W., Lim K.H., Tsai Z.U., Lin R.Y., Lin R.S., Huang C.H. Association of HLA class I with severe acute respiratory syndrome coronavirus infection. BMC Med. Genet. 2003;4:9. - PMC - PubMed
    1. Ng M.H., Lau K.M., Li L., Cheng S.H., Chan W.Y., Hui P.K., Zee B., Leung C.B., Sung J.J. Association of human-leukocyte-antigen class I (B*0703) and class II (DRB1*0301) genotypes with susceptibility and resistance to the development of severe acute respiratory syndrome. J. Infect. Dis. 2004;190:515–518. - PMC - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources